Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H29N5O6 |
Molecular Weight | 447.4849 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)CN1CCN(C[C@@H]2CN(C(=O)O2)C3=CC=C(C=C3)C(=N)NC(=O)OC)CC1
InChI
InChIKey=YNBHAPKHWDNTMZ-QGZVFWFLSA-N
InChI=1S/C21H29N5O6/c1-3-31-18(27)14-25-10-8-24(9-11-25)12-17-13-26(21(29)32-17)16-6-4-15(5-7-16)19(22)23-20(28)30-2/h4-7,17H,3,8-14H2,1-2H3,(H2,22,23,28)/t17-/m1/s1
Molecular Formula | C21H29N5O6 |
Molecular Weight | 447.4849 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Gantofiban (or EMD 122 347) is an oral double prodrug of the drug, EMD 132338 and is GPIIb/IIIa antagonist. The drug participated in phase II clinical trials in Japan in patients with thrombosis. However, in May 2004, Yamanouchi, the developing company, announced that the study was discontinued. Besides gantofiban was involved in phase II trials, like a treatment option in patients with the acute coronary syndrome. However, further information is not available.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:21:16 GMT 2023
by
admin
on
Fri Dec 15 16:21:16 GMT 2023
|
Record UNII |
MRG9KH7HF6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29750
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70171433
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
PRIMARY | |||
|
MRG9KH7HF6
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
PRIMARY | |||
|
C73227
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
PRIMARY | |||
|
9824864
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL78871
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
PRIMARY | |||
|
183547-57-1
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
PRIMARY | |||
|
7836
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
PRIMARY | |||
|
300000036886
Created by
admin on Fri Dec 15 16:21:16 GMT 2023 , Edited by admin on Fri Dec 15 16:21:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|